The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
Inova Health System · Inova Fairfax Hospital
Abstract
BACKGROUND AND AIMS: NAFLD is a leading cause of liver-related morbidity and mortality. We assessed the global and regional prevalence, incidence, and mortality of NAFLD using an in-depth meta-analytic approach. APPROACH AND RESULTS: PubMed and Ovid MEDLINE were searched for NAFLD population-based studies from 1990 to 2019 survey year (last published 2022) per Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Meta-analysis was conducted using random-effects models. Bias risk assessment was per Joanna Briggs Institute. Of 2585 studies reviewed, 92 studies (N=9,361,716) met eligibility criteria. Across the study period (1990-2019), meta-analytic pooling of NAFLD prevalence estimates…
Citation impact
- FWCI
- 584.09
- Percentile
- 100%
- References
- 39
Authors
6Topics & keywords
- Medicine
- Nonalcoholic fatty liver disease
- Internal medicine
- Meta-analysis
- Incidence (geometry)
- Population
- Epidemiology
- Systematic review
- Good health and well-being